Location History:
- Shoufeng, Hualien, TW (2001)
- Taichung, TW (2013 - 2015)
Company Filing History:
Years Active: 2001-2015
Title: Yew-Min Tzeng: Innovator in Chemical Synthesis
Introduction
Yew-Min Tzeng is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of chemical synthesis, particularly in the development of methods for producing antrocin, a compound with potential applications in cancer treatment. With a total of four patents to his name, Tzeng's work is recognized for its innovative approaches and practical applications.
Latest Patents
Tzeng's latest patents include a method for the chemical synthesis of antrocin and its use in suppressing non-small cell lung cancer. This invention outlines a process for preparing antrocin and its pharmaceutically acceptable salts through a series of gold-catalyzed cyclizations, ultimately constructing a (6-6-5) tricyclic core frame. Additionally, he has developed a process for preparing optically active antrocin, which involves the introduction of the correct configuration of trans-decalone and the resolution of racemic nitrile-decalone using chiral diol. This synthesis is completed in ten steps with a 7% overall yield from commercially available 6-methoxy-2-tetralone.
Career Highlights
Throughout his career, Tzeng has demonstrated a commitment to advancing chemical synthesis techniques. His innovative methods have not only contributed to academic research but also hold promise for practical applications in pharmaceuticals. His work exemplifies the intersection of scientific research and real-world application, particularly in the fight against cancer.
Collaborations
Tzeng has collaborated with notable colleagues such as Chi-Tai Yeh and Zhen Yang. These partnerships have likely enriched his research and contributed to the successful development of his patented methods.
Conclusion
Yew-Min Tzeng stands out as a significant figure in the field of chemical synthesis, with a focus on developing methods that have the potential to impact cancer treatment. His innovative patents reflect his dedication to advancing science and improving health outcomes.